- Price
- $400.73
- Day
- -1.45%
- Mkt Cap
- $86.76B
- 52W Range
- $353.99 – $556.52
- Volume
- 1.06M
- Beta
- 1.13
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
If you purchased or acquired stock in HCA and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at [email protected] or by telephone at (212) 355-4648.
Read full article
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read full article
The law firm of [url="]Kirby McInerney LLP[/url] reminds investors of its investigation on behalf of HCA Healthcare, Inc. (âHCA Healthcareâ or the âCompan
Read full article
NEW YORK--(BUSINESS WIRE)---- $HCA #classaction--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On July 14, 2026, HCA Healthcare issued a press release reporting its preliminary financial and operat.
Read full article
NEW YORK, July 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc.("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read full article
U.S. Fund A Shares (without sales charge) posted a return of -0.04% in second quarter of 2026. Leading contributors in the First Eagle U.S. Fund this quarter included Alphabet Inc. Class C, Texas Instruments, Elevance Health, Bank of New York Mellon Corporation and Cummins. The leading detractors in the quarter were First Eagle Global Real Assets Cayman Fund Ltd. USD, HCA Healthcare, Charter Communications, Inc. Class A, Exxon Mobil and Salesforce.
Read full article
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read full article
HCA Healthcare Inc. (NYSE:HCA) on Friday posted upbeat second-quarter earnings.
Read full article
HCA Healthcare (NYSE: HCA) said its second-quarter performance reflected solid demand in several service lines and 11% growth in diluted earnings per share, but the company faced increased financial pressure as patients losing health insurance exchange coverage shifted largely into the uninsured population. Chief Executive Officer Sam Hazen said the expiration of enhanced premium tax credits
Read full article
HCA tops Q2 EPS estimates on higher admissions and revenue per admission but trims parts of its 2026 guidance as higher expenses and weaker surgical volumes weigh on results.
Read full article
While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read full article
HCA Healthcare (HCA) came out with quarterly earnings of $7.59 per share, beating the Zacks Consensus Estimate of $7.57 per share. This compares to earnings of $6.84 per share a year ago.
Read full article